Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Inventory (2019 - 2025)

Harmony Biosciences Holdings' Inventory history spans 7 years, with the latest figure at $5.4 million for Q4 2025.

  • For Q4 2025, Inventory fell 25.58% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, down 25.58%, while the annual FY2025 figure was $5.4 million, 25.58% down from the prior year.
  • Inventory for Q4 2025 was $5.4 million at Harmony Biosciences Holdings, down from $7.0 million in the prior quarter.
  • Across five years, Inventory topped out at $7.2 million in Q4 2024 and bottomed at $3.9 million in Q3 2022.
  • The 5-year median for Inventory is $5.1 million (2022), against an average of $5.4 million.
  • The largest annual shift saw Inventory skyrocketed 107.92% in 2021 before it dropped 25.58% in 2025.
  • A 5-year view of Inventory shows it stood at $4.4 million in 2021, then increased by 10.92% to $4.9 million in 2022, then rose by 9.09% to $5.4 million in 2023, then surged by 34.22% to $7.2 million in 2024, then decreased by 25.58% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Inventory are $5.4 million (Q4 2025), $7.0 million (Q3 2025), and $6.3 million (Q2 2025).